November 24 (SeeNews) - Serbia expects to receive next month its first doses of Molnupiravir, the COVID-19 antiviral drug of US-based drugmaker Merck, the director of Serbia's Republic Fund of Health Insurance, Sanja Radojevic Skodric, said on Wednesday.